How do I get Gleevec (STI571)?
Gleevec (Glivec) has been approved for prescription use in the following countries: Argentina, Australia, Bulgaria, Canada, Chile, Columbia, Dominican Republic, Ecuador, El Salvador, Guatemala, Israel, Indonesia, Japan, Jordan, Kuwait, Malta, Mexico, Nicaragua, Palestine, Peru, Romania, Russia, South Korea, Switzerland, Syria, United States, Uruguay, Venezuela. In other countries Gleevec (STI571) is only available at designated Trial Centers. In these countries patients must meet the entry criteria of one of the trial protocols and be accepted into a trial to get the drug. Click here for Gleevec Trials information from the National Institutes of Health. For the most recent up-to-date information on trials, contact Novartis in the U.S. at: Novartis Oncology Clinical Trials Hot-Line 1-877-Gleevec (1-877-453-3832) Monday through Friday, between 9 AM and 8 PM Eastern Time, or call anytime to leave a message. Click here for Trials Contacts in other parts of the world.
